.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Cantor Fitzgerald
Healthtrust
Farmers Insurance
QuintilesIMS
Fuji
Johnson and Johnson
Chubb
Argus Health

Generated: December 14, 2017

DrugPatentWatch Database Preview

Claims for Patent: RE41920

« Back to Dashboard

Claims for Patent: RE41920

Title:Isobutylgaba and its derivatives for the treatment of pain
Abstract:The instant invention is a method of using certain analogs of glutamic acid and gamma-aminobutyric acid in pain therapy.
Inventor(s): Singh; Lakhbir (Cambridgeshire, GB)
Assignee: Warner-Lambert Company LLC (New York, NY)
Application Number:11/983,750
Patent Claims: 1. A method for treating pain comprising administering a therapeutically effective amount of a compound of Formula I ##STR00002## or a pharmaceutically acceptable salt, diastereomer, or enantiomer thereof wherein R.sub.1 is a straight or branched alkyl of from 1 to 6 carbon atoms, phenyl, or cycloalkyl of from 3 to 6 carbon atoms; R.sub.2 is hydrogen or methyl; and R.sub.3 is hydrogen, methyl, or carboxyl to a mammal in need of said treatment..].

2. A method .[.according to claim 1.]. .Iadd.for treating pain comprising administering a therapeutically effective amount of a compound of Formula I ##STR00003## or a pharmaceutically acceptable salt thereof, .Iaddend..[.wherein the compound administered is a compound of Formula I.]. wherein R.sub.3 and R.sub.2 are hydrogen, and R.sub.1 is .[.--(CH.sub.2).sub.0-2--i C.sub.4H.sub.9.]. .Iadd.isobutyl .Iaddend.as an .[.(R),.]. (S).[., or (R,S).]. isomer.Iadd., to a mammal in need of said treatment.Iaddend..

.[.3. A method according to claim 1 wherein the compound administered is named (S)-3-(aminomethyl)-5-methylhexanoic acid and 3-aminomethyl-5-methylhexanoic acid..].

4. A method according to claim .[.1.]. .Iadd.2 .Iaddend.wherein the pain treated is inflammatory pain.

5. A method according to claim .[.1.]. .Iadd.2 .Iaddend.wherein the pain treated is neuropathic pain.

6. A method according to claim .[.1.]. .Iadd.2 .Iaddend.wherein the pain treated is cancer pain.

7. A method according to claim .[.1.]. .Iadd.2 .Iaddend.wherein the pain treated is postoperative pain.

8. A method according to claim .[.1.]. .Iadd.2 .Iaddend.wherein the pain treated is phantom .[.limit.]. .Iadd.limb .Iaddend.pain.

9. A method according to claim .[.1.]. .Iadd.2 .Iaddend.wherein the pain treated is .[.bum.]. .Iadd.burn .Iaddend.pain.

10. A method according to claim .[.1.]. .Iadd.2 .Iaddend.wherein the pain treated is gout pain.

11. A method according to claim .[.1.]. .Iadd.2 .Iaddend.wherein the pain treated is osteoarthritic pain.

12. A method according to claim .[.1.]. .Iadd.2 .Iaddend.wherein the pain treated is trigeminal neuralgia pain.

13. A method according to claim .[.1.]. .Iadd.2 .Iaddend.wherein the pain treated is acute herpetic and postherpetic pain.

14. A method according to claim .[.1.]. .Iadd.2 .Iaddend.wherein the pain treated is causalgia pain.

15. A method according to claim .[.1.]. .Iadd.2 .Iaddend.wherein the pain treated is idiopathic pain.

.Iadd.16. A method for treating pain comprising administering a therapeutically effective amount of (S)-3-(aminomethyl)-5-methylhexanoic acid, or a pharmaceutically acceptable salt thereof, to a human in need of said treatment..Iaddend.

.Iadd.17. A method according to claim 16 wherein the compound administered is (S)-3-(aminomethyl)-5-methylhexanoic acid..Iaddend.

.Iadd.18. A method according to claim 16 wherein the compound administered is a pharmaceutically acceptable salt of (S)-3-(aminomethyl)-5-methylhexanoic acid..Iaddend.

.Iadd.19. A method according to claim 17 wherein the pain treated is chronic pain..Iaddend.

.Iadd.20. A method according to claim 17 wherein the pain treated is selected from the group consisting of inflammatory pain, neuropathic pain, cancer pain, postoperative pain, and idiopathic pain..Iaddend.

.Iadd.21. A method according to claim 17 wherein the pain treated is neuropathic pain..Iaddend.

.Iadd.22. A method according to claim 17 wherein the pain treated is diabetic neuropathic pain..Iaddend.

.Iadd.23. A method according to claim 17 wherein the pain treated is acute herpetic pain..Iaddend.

.Iadd.24. A method according to claim 17 wherein the pain treated is postherpetic pain..Iaddend.

.Iadd.25. A method according to claim 17 wherein the pain treated is fibromyalgia pain..Iaddend.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
QuintilesIMS
Farmers Insurance
Accenture
AstraZeneca
Mallinckrodt
Daiichi Sankyo
Argus Health
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot